Diuretic use, progressive heart failure, and death in patients in the studies of left ventricular dysfunction (SOLVD)
Authors:
- Michael DomanskiMDMichael Domanski
- James NormanJNJames Norman
- Bertram PittBPBertram Pitt
- Mark HaigneyMHMark Haigney
- Stephen HanlonSHStephen Hanlon
- Eliot PeysterEPEliot Peyster
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA‐salt hypertensive ratsBritish Journal of Pharmacology, 2002
- Aldosterone and Spironolactone in Heart FailureNew England Journal of Medicine, 1999
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery diseaseThe American Journal of Cardiology, 1995
- Chronic administration of aldosterone depresses baroreceptor reflex function in the dog.Hypertension, 1994
- Aldosterone and antialdosterone therapy in congestive heart failureThe American Journal of Cardiology, 1993
- Studies of Left Ventricular Dysfunction (SOLVD)—Rationale, design and methods: Two trials that evaluate the effect of enalapril in patients with reduced ejection fractionThe American Journal of Cardiology, 1990
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Hormones and the Pathogenesis of Congestive Heart Failure:Vasopressin, Aldosterone, and Angiotensin IICirculation, 1962
- THE EFFECTS OF CHRONIC HEPATIC VENOUS CONGESTION ON THE METABOLISM OF d,l-ALDOSTERONE AND d-ALDOSTERONE*Journal of Clinical Investigation, 1962